At the May 26 Healthcare Packaging Conference & Workshops event in Princeton, NJ, Laure L. Larkin will cover how our stability world is changing, especially as it relates to combination products. Larkin, the packaging validation supervisor for Synthes, will address how stability testing relates to the new global economy its many combination product stakeholders. Attendees will learn the U.S. FDA governing documents as well as the ISO (Intl. Organization for Standardization) counterparts.
Helpful information sources will be discussed along with requirements device companies omit when they enter the combination product arena. Finally, the session will provide information on deciding on strategies for combination product stability testing and understanding the stability risk.
Synthes is a leading international medical device company, specializing in the development, manufacturing, and marketing of instruments and implants. Larkin brings more than 20 years of experience in FDA-regulated industries, and has worked with both larger Fortune 100 companies and smaller entrepreneurial organizations. She has functional experience in validation activities related to stability, packaging, cleaning, equipment, software, and test methods, as well as general compliance and risk management.
Understanding best practices for combination product package stability and validation
Hear Synthes USA's Packaging Validation Supervisor Laure L. Larkin explain FDA governing documents as well as the ISO counterparts.
Apr 28, 2011
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
